Beth Israel Deaconess Med Ctr; Hem/Onc
330 Brookline Avenue
Boston, Massachusetts 02215

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Beth Israel Deaconess Med Ctr; Hem/Onc
mi
from
Boston, MA
Click here to add this to my saved trials